Srs Capital Advisors, Inc. Novartis Ag Transaction History
Srs Capital Advisors, Inc.
- $1.5 Billion
- Q4 2024
A detailed history of Srs Capital Advisors, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Srs Capital Advisors, Inc. holds 1,037 shares of NVS stock, worth $116,019. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,037
Previous 983
5.49%
Holding current value
$116,019
Previous $113,000
11.5%
% of portfolio
0.01%
Previous 0.01%
Shares
21 transactions
Others Institutions Holding NVS
# of Institutions
1,477Shares Held
134MCall Options Held
1.31MPut Options Held
1.56M-
Dodge & Cox San Francisco, CA12.2MShares$1.37 Billion0.74% of portfolio
-
Primecap Management CO Pasadena, CA11MShares$1.23 Billion0.85% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.18MShares$916 Million0.2% of portfolio
-
Morgan Stanley New York, NY6.87MShares$769 Million0.05% of portfolio
-
Loomis Sayles & CO L P5.58MShares$624 Million0.68% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $241B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...